TGFB1 and neoplasm: Many other studies have shown that Tregs in tumors inhibit anti-tumor immune responses by suppressing the production of inhibitory cytokines (e.g., IL-10, TGF-β, IL-35) and suppressing anti-tumor immune responses (52, 53).